Matches in SemOpenAlex for { <https://semopenalex.org/work/W3174483220> ?p ?o ?g. }
- W3174483220 abstract "Background: Prognostic factors for elderly patients ≥60 years of age with classical Hodgkin Lymphoma (cHL) are not well established. Previous studies have shown that patient-related factors such as comorbidities and performance status (ECOG-PS), disease-specific factors (extranodal disease) and markers of host inflammation (e.g. neutrophil-lymphocyte ratio [NLR]) can be associated with clinical outcomes in elderly patients with cHL. Therefore the aim of this study was to evaluate the association of cause-specific survival (CSS) and overall survival (OS) with age, stage, Charlson comorbidity index (CCI) and these additional patient- and disease-related factors in a large dataset of elderly patients with cHL. Method: Joint analysis of Princess Margaret and Swiss elderly cHL databases of patients from 2000 to 2018. Main inclusion criteria were age ≥60 years, diagnosis of cHL, treatment with chemotherapy (CT) or combined modality therapy (CMT). Patients with nodular-lymphocyte predominate HL (NLPHL) and treated with radiotherapy alone were excluded. Univariable and multivariable models were applied. Results: Overall, 309 patients from 1 Canadian (n = 72) and 15 Swiss centers (n = 237) were included. Excluded were 10 patients with RT alone and 11 with NLPHL. Median age was 70 years (range 60 – 91), median CCI was 7 (4 – 16), 17.2% of patients had stage I, 30.1 % stage II, 29.9% stage III and 28.5% stage IV cHL. Overall, 5-years OS was 62.4% [95%CI 56.8 – 68.5] and 5-years CSS was 82.6% [78.1 – 87.4]. 189 (61.2%) patients were treated with CT alone, 120 (38.8.%) patients with CMT; 240 (77.7%) patients received anthracycline-containing CT, 69 (22.3%) patients received non-anthracycline-containing CT. In univariable analysis, age, stage, CCI, NLR and ECOG-PS showed significant associations with both endpoints, all p-values < 0.01. Results of the multivariable analysis are demonstrated in table1. Conclusion: In this large, international cohort of patients aged ≥60 years with cHL age, CCI and ECOG-PS are independent factors associated with OS. Age and stage are independently associated with cause-specific survival while NLR and extranodal disease are not independently associated with clinical outcomes. *contributed equally Keywords: Diagnostic and Prognostic Biomarkers, Hodgkin lymphoma No conflicts of interest pertinent to the abstract." @default.
- W3174483220 created "2021-07-05" @default.
- W3174483220 creator A5010836517 @default.
- W3174483220 creator A5013978852 @default.
- W3174483220 creator A5014347189 @default.
- W3174483220 creator A5014978677 @default.
- W3174483220 creator A5016787940 @default.
- W3174483220 creator A5020563845 @default.
- W3174483220 creator A5022825869 @default.
- W3174483220 creator A5025268190 @default.
- W3174483220 creator A5026467222 @default.
- W3174483220 creator A5038115278 @default.
- W3174483220 creator A5038247067 @default.
- W3174483220 creator A5038475711 @default.
- W3174483220 creator A5041567047 @default.
- W3174483220 creator A5043000120 @default.
- W3174483220 creator A5045139107 @default.
- W3174483220 creator A5046258011 @default.
- W3174483220 creator A5048283327 @default.
- W3174483220 creator A5051574325 @default.
- W3174483220 creator A5057869933 @default.
- W3174483220 creator A5058698120 @default.
- W3174483220 creator A5061856914 @default.
- W3174483220 creator A5062829189 @default.
- W3174483220 creator A5067291402 @default.
- W3174483220 creator A5070959932 @default.
- W3174483220 creator A5073165908 @default.
- W3174483220 creator A5074997487 @default.
- W3174483220 creator A5075117420 @default.
- W3174483220 creator A5081286423 @default.
- W3174483220 creator A5082596238 @default.
- W3174483220 creator A5083673759 @default.
- W3174483220 creator A5083858828 @default.
- W3174483220 creator A5090761384 @default.
- W3174483220 date "2021-06-01" @default.
- W3174483220 modified "2023-09-27" @default.
- W3174483220 title "PROGNOSTIC FACTORS IN ELDERLY PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA ‐ A JOINT ANALYSIS OF TWO CLINICAL DATABASES" @default.
- W3174483220 doi "https://doi.org/10.1002/hon.113_2880" @default.
- W3174483220 hasPublicationYear "2021" @default.
- W3174483220 type Work @default.
- W3174483220 sameAs 3174483220 @default.
- W3174483220 citedByCount "0" @default.
- W3174483220 crossrefType "journal-article" @default.
- W3174483220 hasAuthorship W3174483220A5010836517 @default.
- W3174483220 hasAuthorship W3174483220A5013978852 @default.
- W3174483220 hasAuthorship W3174483220A5014347189 @default.
- W3174483220 hasAuthorship W3174483220A5014978677 @default.
- W3174483220 hasAuthorship W3174483220A5016787940 @default.
- W3174483220 hasAuthorship W3174483220A5020563845 @default.
- W3174483220 hasAuthorship W3174483220A5022825869 @default.
- W3174483220 hasAuthorship W3174483220A5025268190 @default.
- W3174483220 hasAuthorship W3174483220A5026467222 @default.
- W3174483220 hasAuthorship W3174483220A5038115278 @default.
- W3174483220 hasAuthorship W3174483220A5038247067 @default.
- W3174483220 hasAuthorship W3174483220A5038475711 @default.
- W3174483220 hasAuthorship W3174483220A5041567047 @default.
- W3174483220 hasAuthorship W3174483220A5043000120 @default.
- W3174483220 hasAuthorship W3174483220A5045139107 @default.
- W3174483220 hasAuthorship W3174483220A5046258011 @default.
- W3174483220 hasAuthorship W3174483220A5048283327 @default.
- W3174483220 hasAuthorship W3174483220A5051574325 @default.
- W3174483220 hasAuthorship W3174483220A5057869933 @default.
- W3174483220 hasAuthorship W3174483220A5058698120 @default.
- W3174483220 hasAuthorship W3174483220A5061856914 @default.
- W3174483220 hasAuthorship W3174483220A5062829189 @default.
- W3174483220 hasAuthorship W3174483220A5067291402 @default.
- W3174483220 hasAuthorship W3174483220A5070959932 @default.
- W3174483220 hasAuthorship W3174483220A5073165908 @default.
- W3174483220 hasAuthorship W3174483220A5074997487 @default.
- W3174483220 hasAuthorship W3174483220A5075117420 @default.
- W3174483220 hasAuthorship W3174483220A5081286423 @default.
- W3174483220 hasAuthorship W3174483220A5082596238 @default.
- W3174483220 hasAuthorship W3174483220A5083673759 @default.
- W3174483220 hasAuthorship W3174483220A5083858828 @default.
- W3174483220 hasAuthorship W3174483220A5090761384 @default.
- W3174483220 hasConcept C126322002 @default.
- W3174483220 hasConcept C143998085 @default.
- W3174483220 hasConcept C146357865 @default.
- W3174483220 hasConcept C151730666 @default.
- W3174483220 hasConcept C2779134260 @default.
- W3174483220 hasConcept C2779159551 @default.
- W3174483220 hasConcept C2779338263 @default.
- W3174483220 hasConcept C2779714933 @default.
- W3174483220 hasConcept C2910914307 @default.
- W3174483220 hasConcept C2992779791 @default.
- W3174483220 hasConcept C38180746 @default.
- W3174483220 hasConcept C509974204 @default.
- W3174483220 hasConcept C71924100 @default.
- W3174483220 hasConcept C86803240 @default.
- W3174483220 hasConceptScore W3174483220C126322002 @default.
- W3174483220 hasConceptScore W3174483220C143998085 @default.
- W3174483220 hasConceptScore W3174483220C146357865 @default.
- W3174483220 hasConceptScore W3174483220C151730666 @default.
- W3174483220 hasConceptScore W3174483220C2779134260 @default.
- W3174483220 hasConceptScore W3174483220C2779159551 @default.
- W3174483220 hasConceptScore W3174483220C2779338263 @default.
- W3174483220 hasConceptScore W3174483220C2779714933 @default.
- W3174483220 hasConceptScore W3174483220C2910914307 @default.
- W3174483220 hasConceptScore W3174483220C2992779791 @default.
- W3174483220 hasConceptScore W3174483220C38180746 @default.